Prostate‐specific antigen‐based screening for prostate cancer: Evidence, controversies and future perspectives
Author:
- 28 April 2009
- journal article
- review article
- Published by Wiley in International Journal of Urology
- Vol. 16 (5) , 458-464
Abstract
The most recent epidemiological survey revealed that the mortality rate for prostate cancer in Japan has increased and has been getting very close to that in the USA, where it has decreased since 1992. The low exposure rate of prostate‐specific antigen (PSA) screening in Japan and the high exposure rate of PSA screening in the USA may result in completely deferent trends in the mortality rate of prostate cancer between the two countries. The Japanese Urological Association recommends PSA‐based screening for men at risk of prostate cancer at age 50 years or older in general and 45 years or older in men with a family history of prostate cancer within first generation relatives. The fact sheet on screening for prostate cancer should indicate the most recent reliable clinical research on screening for prostate cancer and its demerits including false‐negative and false‐positive PSA test results and prostate biopsy, overdetection and overtreatment. However, it should be explained to the public that the demerits for PSA screening will be clarified step by step during screening, and in general, men having more information on screening results (PSA level, pathological findings of biopsy specimens, clinical stage, etc.) can understand their current situation better than those having no information on screening results, including PSA levels.Keywords
This publication has 40 references indexed in Scilit:
- Japanese Urological Association guidelines on prostate‐specific antigen‐based screening for prostate cancer and the ongoing cluster cohort study in JapanInternational Journal of Urology, 2008
- Timing of Androgen Deprivation Therapy and its Impact on Survival After Radical Prostatectomy: A Matched Cohort StudyJournal of Urology, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomyThe Lancet Oncology, 2006
- American Cancer Society Guidelines for the Early Detection of Cancer, 2006CA: A Cancer Journal for Clinicians, 2006
- Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological AssociationInternational Journal of Urology, 2005
- Prostate carcinoma detection and increased prostate‐specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screeningCancer, 2005
- An Ecologic Study of Prostate-specific Antigen Screening and Prostate Cancer Mortality in Nine Geographic Areas of the United StatesAmerican Journal of Epidemiology, 2004
- Screening Men for Prostate and Colorectal Cancer in the United StatesJAMA, 2003
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997